—In a new study, the extent of microstructural damage in patients with early relapsing-remitting multiple sclerosis (RRMS) was associated with worse disability and spinal cord atrophy at 5 years. Here ...

Radiomics offers improved assessment of spinal cord pathology in MS, surpassing conventional MRI in precision and sensitivity. A study identified 12 significant radiomic features, with four ...

Mavenclad resulted in stable/better cognitive function and stable employment status over 2 years in highly active relapsing ...

NervGen is a Canadian early-stage biotech company with unprecedented preclinical work in spinal cord injury and multiple sclerosis. The company is finalizing a Phase 1 clinical trial for its ‘pipeline ...

Medthera's WalkPort is designed to help people with mobility and gait issues, including those with MS, safely stand and ...

Researchers compare cerebral spinal fluid samples, identifying novel proteins, heightened immune cell activity and hormonal ...

It took years for actress Selma Blair to find the role of a lifetime, and joy, in a shocking diagnosis. Discovering in her ...